glp-1 headaches Headache and receptor agonists: when medications are therapeutic and when they contribute to the symptom GLP-1 Receptor Agonists have an

A 43-year-old man with obesity and insulin pump therapy reduced his total daily dose by 30% within the first month of GLP-1 use

Mounjaro Mounjaro contains tirzepatide, a dual GLP-1 and GIP receptor agonist that supports blood sugar regulation and appetite control

Acknowledgements This work was supported by the Burroughs Wellcome Fund (BWF) in Pathogenesis of Infectious Disease (PATH award to B.P.C., PATH award to S.H.), the National Institutes of Health (NIH) (R01AI173004 and R01AI179695 to B.P.C

The future of oral tirzepatide The story of oral tirzepatide is not over

A minimally invasive laser liposuction treatment follows a clear, step-by-step process that sets it apart from other fat reduction options